Try a new search

Format these results:

Searched for:

in-biosketch:true

person:bermar01

Total Results:

220


Imiquimod -- a TLR 7 agonist as vaccine adjuvant [Meeting Abstract]

Adams S; O'Neill D; Pavlick A; Hardin E; Nonaka D; Chiriboga L; Siu K; Shapiro R; Berman R; Strober B; Cruz C; Angiulli A; Manchez O; Berner N; Mukhi V; Shao Y; Bhardwaj N
ORIGINAL:0006152
ISSN: 0736-7589
CID: 73377

Clinical relevance of neutral endopeptidase overexpression in melanoma [Meeting Abstract]

Yancovitz, M; Velazquez, E; Christos, P; Pavlick, A; Berman, R; Shapiro, R; Bhardwaj, N; Nanus, D; Polsky, D; Osman, I
ISI:000239009403139
ISSN: 0732-183x
CID: 69301

Neutral endopeptidase (NEP) overexpression is associated with progression in malignant melanoma (MM) and is a potential target of treatment [Meeting Abstract]

Velazquez, EF; Yancovitz, M; Sorhaindo, L; Bogunovic, D; O'Neill, D; Shapiro, R; Pavlick, A; Berman, R; Bhardwaj, N; Spira, J; Christos, P; Nanus, D; Polsky, D; Osman, I
ISI:000234094500401
ISSN: 0893-3952
CID: 61435

Expression of cancer testis (CT) antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM), correlation with prognostic factors and potential role in a melanoma vaccine [Meeting Abstract]

Velazquez, EF; Jungbluth, AA; Osman, I; Yancovitz, M; Adams, S; O'Neill, D; Zavilevich, K; Albukh, T; Pavlick, A; Polsky, D; Shapiro, R; Berman, R; Spira, J; Busam, K; Bhardwaj, N
ISI:000234094500400
ISSN: 0893-3952
CID: 61434

Expression of cancer testis (CT) antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM), correlation with prognostic factors and potential role in a melanoma vaccine [Meeting Abstract]

Velazquez, EF; Jungbluth, AA; Osman, I; Yancovitz, M; Adams, S; O'Neill, D; Zavilevich, K; Albukh, T; Pavlick, A; Polsky, D; Shapiro, R; Berman, R; Spira, J; Busam, K; Bhardwaj, N
ISI:000234207600400
ISSN: 0023-6837
CID: 62615

Neutral endopeptidase (NEP) overexpression is associated with progression in malignant melanoma (MM)and is a potential target of treatment [Meeting Abstract]

Velazquez, EF; Yancovitz, M; Sorhaindo, L; Bogunovic, D; O'Neill, D; Shapiro, R; Pavlick, A; Berman, R; Bhardwaj, N; Spira, J; Christos, P; Nanus, D; Polsky, D; Osman, I
ISI:000234207600401
ISSN: 0023-6837
CID: 62616

Management of complicated peptic ulcer disease [Letter]

Liang, Mike K; Marks, Jenifer L; Berman, Russell S; Carter, Joseph
PMID: 16172300
ISSN: 0004-0010
CID: 96138

Primary squamous cell carcinoma of the colon associated with hypercalcemia and hyperleukocytosis. Report of a case [Case Report]

Yitta, Silaja; Liang, Mike K; Berman, Russell; Carter, Joseph J; Yee, Herman T; Marks, Jenifer L
BACKGROUND/AIMS: Squamous cell carcinoma of the colon is a rare entity. We report a case of a patient who presented with a perforated squamous cell carcinoma of the sigmoid colon. RESULTS: A 45-year-old female presented with a 2-month history of worsening abdominal pain, bloody diarrhea, and vomiting. She underwent an exploratory laparotomy and was found to have keratinizing squamous cell carcinoma of the sigmoid colon that had perforated forming multiple abscess cavities. The postoperative course was complicated by hypercalcemia and persistent hyperleukocytosis, ultimately resulting in the patient's death. CONCLUSIONS: We present the second reported case of squamous cell carcinoma of the colon associated with hypercalcemia and the first reported case of associated hyperleukocytosis
PMID: 16424667
ISSN: 0253-4886
CID: 64455

Increased apoptosis in metastatic human colonic adenocarcinomas

Termuhlen, Paula M; Sweeney-Gotsch, Bridget M; Berman, Russell S; Ellis, Lee M; Bucana, Corazon; Shen, Yu; Cleary, Karen R; McConkey, David J
Recent work suggests that apoptosis is disrupted during the progression of many solid tumors. Isogenic metastatic colon adenocarcinoma cells displayed significantly higher levels of staurosporine-induced apoptosis compared to their nonmetastatic counterparts in vitro. In addition, analysis of 15 matched primary tumors and liver metastases demonstrated that the levels of apoptosis were significantly higher in the metastases, and this increased cell death was associated with significantly lower levels of Bcl-2 protein expression. Our data demonstrate that the molecular events associated with acquisition of the metastatic phenotype sensitize colon cancer cells to some pro-apoptotic stimuli
PMID: 12170764
ISSN: 1538-4047
CID: 141467

How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma?

Porter GA; Ross MI; Berman RS; Sumner WE; Lee JE; Mansfield PF; Gershenwald JE
BACKGROUND: Sentinel lymph node (SLN) biopsy has been shown to reliably identify nodal metastases and the subsequent need for further surgical and adjuvant therapy in patients with cutaneous melanoma. Although SLN identification rates have improved with the addition of radioactive colloid to the blue dye technique, it remains unclear how many lymph nodes should be removed to accurately determine the histologic status of the nodal basin. The objective of this study was to determine the optimal extent of SLN biopsy in these patients. METHODS: The records of 633 consecutive patients with melanoma (765 nodal basins) whose primary treatment included SLN biopsy with the use of a combination of blue dye and technetium Tc 99 labeled sulfur colloid were reviewed. SLN biopsy consisted of the removal of all of the blue-stained nodes and all nodes with radiotracer uptake activity of at least twice background. RESULTS: SLN biopsy was successful in 765 of 772 basins (99%). A mean of 1.9 SLNs (median, 2 SLNs) per basin were excised. At least 3 SLNs were removed in 176 basins (23%). The overall histologic status of a basin was always established by the first or second SLN harvested (ie, in no patient was the third or subsequent SLN positive when 1 of the first 2 was not). Of the 124 basins containing lymphatic metastases, the SLN that contained the maximal radiotracer uptake (hottest) and/or stained blue was pathologically positive in 118 basins (95%). In only 6 of the 124 positive basins (5%) was the sole evidence of occult nodal metastases identified in an SLN that was neither blue-stained nor the hottest. All but 1 of these SLNs had counts that were at least 66% of the hottest node in the basin. CONCLUSIONS: With a combined modality approach to SLN biopsy, removal of more than 2 SLNs did not provide information that upstaged any patient with primary melanoma. Removal of additional nonblue SLN(s) that contained radioactive counts of at least twice background but lower than two thirds of the SLNs with maximal radiotracer uptake affected patient management in less than 0.2% of all cases. These findings may be helpful in minimizing the extent of surgery and perhaps in reducing the costs and resource use associated with operating room time and pathologic examination
PMID: 10923009
ISSN: 0039-6060
CID: 19434